Anticancer drugs

SYNLAB

The early work of Botta group was devoted to the structural elucidation and synthesis of biological active molecules derived from plant in vivo. Since 1984, his group have been working in the field of in vitro plant tissue cultures. The general aim of the investigation was directed toward the understanding of biosynthetic pathways of the isolated metabolites and the isolation of the responsible enzymes. During this research, new plant enzymes (e.g. peroxidases) have been isolated, purified, and characterized by chemical and kinetic studies.

Informazioni

Struttura
Spin OFF
KET
Keywords
Progetti principali
Altre informazioni

Componenti del gruppo

Nome	E-mail

Collaboratori nazionali ed internazionali

Laboratori

Pubblicazioni

Brevetti

Progetti di ricerca

ERC

ERC	Descrizione

Infrastrutture

Leggi tutto su SYNLAB

Drug repurposing against COVID-19. focus on anticancer agents

The very limited time allowed to face the COVID-19 pandemic poses a pressing challenge to find proper therapeutic approaches. However, synthesis and full investigation from preclinical studies to phase III trials of new medications is a time-consuming procedure, and not viable in a global emergency, such as the one we are facing.